Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 20:32:45 29/07/2026 +04			5-day change	1st Jan Change
488.54 ^USD	-0.38%		+3.61%	+8.00%

04:21pm	Abcellera Biologics Inc. Announces Collaboration with Vertex Pharmaceuticals Incorporated to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions	CI
07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	124,464	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	8.2%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	110,721	105,852	100,823
Change	-	31.13%	47.8%	4.23%	11.09%	2.12%	-4.4%	-4.75%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	28x	24.7x	20.4x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.62x	4.65x	3.91x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.8x	1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.54x	8.67x	7.74x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.49x	7.38x	6.27x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	19.1x	15.9x	13.2x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	20x	16.7x	13.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	22.4x	21.7x	19.6x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.47%	4.6%	5.09%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.54	19.89	24.01
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,046	14,347	16,084
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,789	6,650	7,648
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,525	6,331	7,406
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,518	5,136	6,175
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-13,743	-18,611	-23,641
Reference price ²	219.60	288.78	406.89	402.70	453.36	490.39	490.39	490.39
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.96x	8.49x	19.12x	-.--%	124B
ELI LILLY AND COMPANY	36.25x	12.94x	27.18x	0.55%	1,089B
JOHNSON & JOHNSON	28.59x	6.53x	18.09x	2.01%	643B
ABBVIE INC.	33.13x	7.75x	15.94x	2.61%	465B
ROCHE HOLDING AG	20.2x	4.86x	12.04x	2.72%	359B
NOVARTIS AG	22.65x	5.84x	14.57x	2.74%	303B
ASTRAZENECA PLC	22.03x	4.53x	12.8x	1.93%	267B
NOVO NORDISK A/S	14.79x	5.48x	11.3x	3.38%	226B
AMGEN INC.	25.81x	6.73x	11.86x	2.57%	212B
GILEAD SCIENCES, INC.	-48.4x	5.8x	32.01x	2.45%	167B
Average	18.30x	6.90x	17.49x	2.1%	385.56B
Weighted average by Cap.	25.28x	8.12x	19.09x	1.86%